Featured Research

from universities, journals, and other organizations

Hershey Medical Center To Participate In Study Of Blood Substitute For Trauma Patients

Date:
January 6, 2005
Source:
Penn State
Summary:
Penn State Milton S. Hershey Medical Center was one of a few Level I trauma centers in the U.S. chosen to participate in a national clinical research study to evaluate the safety and efficacy of PolyHeme, an oxygen-carrying blood substitute, in treating critically injured and bleeding patients.

Hershey, Pa. -- Penn State Milton S. Hershey Medical Center was one of a few Level I trauma centers in the U.S. chosen to participate in a national clinical research study to evaluate the safety and efficacy of PolyHeme, an oxygen-carrying blood substitute, in treating critically injured and bleeding patients.

Under the study protocol, treatment would begin before arrival at the hospital, either at the scene of the injury or in the emergency response unit, and continue during a 12-hour post injury period in the hospital. Since blood is not presently carried in ambulances or helicopters, the use of PolyHeme in these settings could address an unmet medical need for an oxygen-carrying solution where blood is not available. The study will compare the survival rate of patients receiving PolyHeme in the ambulance or helicopter, to that of patients who receive the current standard of care, which is saline solution.

"We are excited to be asked to participate in this groundbreaking clinical trial," said Robert Cherry, medical director of the Penn State Hershey Medical Center Trauma Program, assistant professor of surgery in the Penn State College of Medicine, and study principal investigator. "The CDC reports that trauma-related injuries are a leading cause of death among Americans under age 45. The study will investigate whether treating trauma patients very early with an oxygen-carrying solution and keeping their hemoglobin levels up will improve survival."

Because the patients eligible for this study are unable to provide informed consent before receiving PolyHeme due to the extent and nature of their injuries, the study will be conducted under federal regulations that allow for clinical research in emergency settings using an exception from the requirement for informed consent (21 CFR 50.24).

Use of this provision in a study protocol is granted by the institutional review board (IRB) responsible for the initial and continuing review and approval of the research study. Such a decision is based on the finding and documentation that, amongst other things, patients are in a life-threatening situation requiring emergency medical intervention, currently available treatments are unproven or unsatisfactory, obtaining informed consent is not feasible, potential risks are reasonable in relation to what is known of the condition, participation in the study could provide a direct benefit to the patients enrolled, and the research could not be practicably conducted without an exception from informed consent requirements.

The IRB requires that the medical center team present study information at public meetings and in other forums, and collect public comment about the study. Study investigators will present information at January county commissioners' meetings in the following counties: Dauphin, Perry, Cumberland, Lebanon, Lancaster and Schuylkill. The meetings will include the opportunity for members of the public to ask questions and fill out a survey.

The treatment under study, PolyHeme, is a universally-compatible, immediately available, oxygen-carrying resuscitative fluid designed for use in urgent blood loss when blood is not immediately available. It has been studied in trauma trials in the hospital setting. PolyHeme is manufactured by Northfield Laboratories Inc., of Evanston, Ill., http://www.northfieldlabs.com


Story Source:

The above story is based on materials provided by Penn State. Note: Materials may be edited for content and length.


Cite This Page:

Penn State. "Hershey Medical Center To Participate In Study Of Blood Substitute For Trauma Patients." ScienceDaily. ScienceDaily, 6 January 2005. <www.sciencedaily.com/releases/2005/01/050106105114.htm>.
Penn State. (2005, January 6). Hershey Medical Center To Participate In Study Of Blood Substitute For Trauma Patients. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2005/01/050106105114.htm
Penn State. "Hershey Medical Center To Participate In Study Of Blood Substitute For Trauma Patients." ScienceDaily. www.sciencedaily.com/releases/2005/01/050106105114.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Despite Health Questions, E-Cigs Are Beneficial: Study

Despite Health Questions, E-Cigs Are Beneficial: Study

Newsy (July 31, 2014) Citing 81 previous studies, new research out of London suggests the benefits of smoking e-cigarettes instead of regular ones outweighs the risks. Video provided by Newsy
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins